Sustainability | July 26, 2023
Teva Pharmaceuticals engages Honeywell to help reduce carbon impact
Teva will leverage Honeywell’s ‘Energy as a Service’ (EaaS) model
Teva will leverage Honeywell’s ‘Energy as a Service’ (EaaS) model
1. 10 crore teleconsultations have been rendered to senior citizens and 5,22,15,224 to women
Good momentum in commercial CDMO business
The CHMP’s recommendation will now be reviewed by the European Commission for marketing authorization in the European Union
Mage Biologics to develop a monoclonal antibody targeting ulcerative colitis
The Long-term Safety Trial was approved to be conducted by China National Medical Products Administration (NMPA) on 18 April 2023
Advances clinical research capabilities with leading regulatory grade registries platform
Astellas stands on the forefront of healthcare change to turn innovative science into value for patients
Adding 20,000 liters of installed biologics drug substance manufacturing capacity
The 'A+' rating reflects IOL's robust business model, diversified product portfolio
Subscribe To Our Newsletter & Stay Updated
